Cell surface glycocalyx control of immune cell recruitment and pathology in the inflamed brain
In plain English
AI plain-English summaryA sugary coating on blood vessels and immune cells controls whether inflammatory cells can enter the brain—and a new project will test whether manipulating this coating can limit damage after a stroke. This matters because the brain cannot regenerate its neurons, so every inflammatory immune cell that crosses into brain tissue risks causing permanent harm. Chemokines—the molecules that guide immune cells—have long been suspected as drivers of brain inflammation, but drugs targeting them have failed, partly because scientists did not understand how the glycocalyx, a gel-like layer on cell surfaces, physically regulates their activity. The research uses stroke, the second leading cause of death and disability worldwide, as a model to study this overlooked structure. If successful, the work could reveal why existing chemokine-targeting therapies have not worked and point toward new ways to block damaging immune cell entry into the brain after stroke or other inflammatory conditions. This is fundamental science: it aims to transform understanding of a basic mechanism of cell trafficking, not to produce an immediate treatment. Similar fundamental insights into how cells move through tissues have previously led to therapies for autoimmune diseases and cancer immunotherapy.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Career Development AwardPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know